VYROLOGIX
associated with 11 other trademarks
therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for preventing and/or treating HIV, cancer, graft-versus-hos...

Words that describe this trademark:

cell receptor  treating hiv  preventing  targeting  andor  therapeutic  receptor  ccr5  preparations  antibodies 

Serial Number:

88877284

Mark:

VYROLOGIX

Status:

Abandoned-No Statement of Use filed

Status Date:

09-05-2022

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for preventing and/or treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19

Mark Description:

The mark consists of "VYROLOGIX" in stylized letters.

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

12-08-2020

Mark Drawing Status:

Words, Letters, and/or Numbers in Stylized From

Abandon Date:

09-05-2022

Business Name:

SEED IP LAW GROUP LLP

Correspondent Name:

Recent Trademark filings by this company